Metraipolis › archive › dc_fcaf69eab700

Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive… — Europe PMC PMID:42214048

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42214048
DOI
10.1200/go-25-00287
License (as archived)
solo-consultazione
Archived
2026-10-15T17:19:16.913Z
SHA-256 of the archived text
566e3391ec00a9ff46aea0d16a027fb2efaae38cd0523b4d684d4cda689aa71a
Stable URL of this page
https://metraipolis.com/documento/dc_fcaf69eab700

How to cite

Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive… — Europe PMC PMID:42214048 — Europe PMC (en), https://europepmc.org/article/MED/42214048 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcaf69eab700 (Metraipolis archive dc_fcaf69eab700, sha256 566e3391ec00a9ff46aea0d16a027fb2efaae38cd0523b4d684d4cda689aa71a)
BibTeX
@misc{dcfcaf69eab700,
  title = {Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive… — Europe PMC PMID:42214048},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42214048},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcaf69eab700; sha256 566e3391ec00a9ff46aea0d16a027fb2efaae38cd0523b4d684d4cda689aa71a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42214048. Agents can read the archived copy with the MCP tool read_document.